ArticlePloS one2021
New relevance and significance measures to replace p-values.
Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Data Analysis Planning and Reporting for Confirmatory Multi-Lab Preclinical Trials: A Tutorial.Biometrical journal. Biometrische Zeitschrift · 2026Review
- Metabolomic Profiling of Citrus Grafts Challenged byJournal of agricultural and food chemistry · 2025Article
- Quantitative susceptibility mapping of deep brain nuclei in 22q11.2 deletion syndrome.Frontiers in psychiatry · 2025Article
- Transcranial Magnetic Stimulation Facilitates Neural Speech Decoding.Brain sciences · 2024Article
- Article
- Reply to Mathur et al.: Many-analyst studies should consider effect sizes and CIs.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Child stunting and associated risk factors in selected food-insecure areas in Rwanda: an analytical cross-sectional study.The Pan African medical journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The p-value has been debated exorbitantly in the last decades, experiencing fierce critique, but also finding some advocates. The fundamental issue with its misleading interpretation stems from its common use for testing the unrealistic null hypothesis of an effect that is precisely zero. A meaningful question asks instead whether the effect is relevant. It is then unavoidable that a threshold for relevance is chosen. Considerations that can lead to agreeable conventions for this choice are presented for several commonly used statistical situations. Based on the threshold, a simple quantitative measure of relevance emerges naturally. Statistical inference for the effect should be based on the confidence interval for the relevance measure. A classification of results that goes beyond a simple distinction like "significant / non-significant" is proposed. On the other hand, if desired, a single number called the "secured relevance" may summarize the result, like the p-value does it, but with a scientifically meaningful interpretation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.